Loading…

Seroepidemiology of hepatitis B virus infection in İstanbul: A 20-year survey

Objective: Turkey is an intermediate endemic country for hepatitis B virus (HBV) infection, with the prevalence rates showing regional differences. The aim of this study was to determine the recent prevalence of HBV infection among adults in İstanbul and to evaluate the impact of national vaccinatio...

Full description

Saved in:
Bibliographic Details
Published in:Viral hepatit dergisi 2016-12, Vol.22 (3), p.88-91
Main Authors: FURUNCUOGLU, Yavuz, SAGLAM, Filiz, BÖLÜKBAS, Filiz Füsun, BÖLÜKBAS, Cengiz, ÖZTÜRK, Recep
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objective: Turkey is an intermediate endemic country for hepatitis B virus (HBV) infection, with the prevalence rates showing regional differences. The aim of this study was to determine the recent prevalence of HBV infection among adults in İstanbul and to evaluate the impact of national vaccination program that started in 1998. Materials and Methods: Data of three healthcare centers from 3 different districts in İstanbul between 1995 and 2015 were obtained. HBV status of the participants was evaluated according to their hepatitis B surface antigen (HBsAg) and anti-HBs results. The change in HBV prevalence was evaluated by dividing the time included in the study into three periods: 1995-2002, 2003-2009 and 2010-2015. Statistical comparison between groups studied in each period was performed. To evaluate the impact of vaccination, the patients of 15-17 years of age were compared with the rest of the last study group. Results: Totally, 26001 adult patients were included in the study. HBsAg and anti-HBs tested positive in 4.24% and 16.81% of patients, respectively. When the 20 years included in the study were divided into three periods and each studied separately, the positive results for HBsAg decreased from 5.34% to 4.8% and 3.08%, and positive anti-HBs results increased from 14.24% to 15.45% and 19.57%, the difference between the groups being statistically significant (p
ISSN:1307-9441
2147-2939
DOI:10.4274/vhd.30932